STAT3-mediated allelic imbalance of novel genetic variant Rs1047643 and B-cell-specific super-enhancer in association with systemic lupus erythematosus

被引:0
|
作者
Zhang, Yanfeng [1 ]
Day, Kenneth [2 ]
Absher, Devin M. [1 ]
机构
[1] HudsonAlpha Inst Biotechnol, Huntsville, TX 35806 USA
[2] Zymo Res Corp, Irvine, CA USA
来源
ELIFE | 2022年 / 11卷
关键词
allelic imbalance; super-enhancer; STAT3; systemic lupus erythematosus; b-lymphocyte; chromatin accessibility; Human; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; POOR SURVIVAL; RISK VARIANTS; DISEASE; CHROMATIN; GENOME; STAT3; PATHOGENESIS; INDIVIDUALS;
D O I
10.7554/eLife.72837; 10.7554/eLife.72837.sa0; 10.7554/eLife.72837.sa1; 10.7554/eLife.72837.sa2
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mapping of allelic imbalance (AI) at heterozygous loci has the potential to establish links between genetic risk for disease and biological function. Leveraging multi-omics data for AI analysis and functional annotation, we discovered a novel functional risk variant rs1047643 at 8p23 in association with systemic lupus erythematosus (SLE). This variant displays dynamic AI of chromatin accessibility and allelic expression on FDFT1 gene in B cells with SLE. We further found a B-cell restricted super-enhancer (SE) that physically contacts with this SNP-residing locus, an interaction that also appears specifically in B cells. Quantitative analysis of chromatin accessibility and DNA methylation profiles further demonstrated that the SE exhibits aberrant activity in B cell development with SLE. Functional studies identified that STAT3, a master factor associated with autoimmune diseases, directly regulates both the AI of risk variant and the activity of SE in cultured B cells. Our study reveals that STAT3-mediated SE activity and cis-regulatory effects of SNP rs1047643 at 8p23 locus are associated with B cell deregulation in SLE.
引用
收藏
页数:21
相关论文
empty
未找到相关数据